| 摘要 |
The invention features a therapeutic composition containing mammalian, preferably human, post-fetal, AGM cells in a pharmaceutically acceptable carrier. The compositions of the invention can be administered to treat patients suffering from autoimmune diseases, to treat patients in need of organ or cell regeneration, and to treat patients in need of immune, especially hematopoietic, reconstitution. |
